Quantitative analysis of glutathione in human brain tumors
Authors:
- Takaya MioTMTakaya Mio
- Takashi KokunaiTKTakashi Kokunai
- Norihiko TamakiNTNorihiko Tamaki
- Kimiaki SuminoKSKimiaki Sumino
- Satoshi MatsumotoSMSatoshi Matsumoto
- 1 April 1990
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 72 (4) , 610-615
Abstract
✓ Reduced glutathione (γ-glutamylcysteinylglycine, GSH) plays an important role in the protection of cells against damage from free radicals and other electrophils and also influences cellular radiosensitivity, cellular response to hyperthermia, and cytotoxicity to some kinds of chemotherapeutic agents. The concentrations of GSH in 40 primary and metastatic brain tumors were quantitatively analyzed, and GSH was localized in these tumors by a novel o-phthalaldehyde histofluorescence method. The level of GSH was 195.2 ± 57.1 µg/gm (mean ± standard deviation) in glioblastomas multiforme, 444.1 ± 105.1 µg/gm in normal brain tissues, and 614.4 ± 237.4 µg/gm in meningiomas. The differences in GSH levels between glioblastomas and normal brain tissues and between glioblastomas and meningiomas were statistically significant (p < 0.01). The mean GSH level in astrocytoma grades II and III was 321.9 ± 11.8 µg/gm. The difference in the GSH level between glioblastomas and astrocytomas was statistically significant (p < 0.05). Radiosensitive tumors, such as multiple myeloma, germinoma, and small-cell carcinoma, showed low GSH levels. These data suggest the possibility that the GSH may be a predictor for the efficacy of radiation therapy. The cytochemical study showed GSH localized in the cytoplasm; although it stained well in meningioma tissue, GSH was not well stained in sections of multiple myeloma. The endothelial proliferation did not stain well in glioblastoma, which seems to imply that this area is vulnerable to attack by free radicals from irradiation and/or chemotherapy.Keywords
This publication has 11 references indexed in Scilit:
- Glutathione localization by a novelo-phthalaldehyde histofluorescence methodJournal of Molecular Histology, 1986
- Regulation of reductive processes by glutathioneBiochemical Pharmacology, 1986
- Effects of Glutathione Depletion by Buthionine Sulfoximine on Radiosensitization by Oxygen and Misonidazole in VitroRadiation Research, 1985
- Glutathione Depletion, Radiosensitization, and Misonidazole Potentiation in Hypoxic Chinese Hamster Ovary Cells by Buthionine SulfoximineRadiation Research, 1984
- Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)Biochemical Pharmacology, 1983
- Radiosensitization of Hypoxic Tumor Cells by Depletion of Intracellular GlutathioneScience, 1982
- Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytesBiochemical Pharmacology, 1981
- The Glutathione Status of Cells1978
- A fluorometric method for determination of oxidized and reduced glutathione in tissuesAnalytical Biochemistry, 1976
- Glutathione Metabolism and Some Possible Functions of Glutathione in the Nervous System1976